Clinical Trial Update: Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating blinatumomab for relapsed acute B-lymphoblastic leukemia after transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Blinatumomab (blinatumomab)

Snippet

Sponsor: Suping ZHANG | Conditions: Acute B-cell Lymphoblastic Leukemia | Phase 4 | Status: RECRUITING